ALUR
Allurion Technologies Inc.
Price Chart
Latest Quote
$1.24
Current Price| Previous Close | $1.35 |
| Open | $1.35 |
| Day High | $1.39 |
| Day Low | $1.17 |
| Volume | 176,019 |
Stock Information
| Shares Outstanding | 12.28M |
| Total Debt | $83.29M |
| Cash Equivalents | $6.14M |
| Revenue | $17.21M |
| Net Income | $-32.33M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $15.24M |
| EPS (TTM) | $-16.20 |
| Exchange | NYQ |
đ Custom Metrics & Score
Score: 13/42| Debt to Equity | -0.49 |
| Debt to Earnings | 1.76 |
| Current Ratio | 1.44 |
| Quick Ratio | 1.19 |
| Avg Revenue Growth | -4.01% |
| Profit Margin | -22.42% |
| Return on Equity | 9.23% |
| Avg FCF Growth | 82.58% |
| FCF Yield | -430.37% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $1.24 | 177,300 |
| 2026-01-30 | $1.35 | 44,800 |
| 2026-01-29 | $1.45 | 57,200 |
| 2026-01-28 | $1.48 | 29,300 |
| 2026-01-27 | $1.52 | 92,300 |
| 2026-01-26 | $1.40 | 165,100 |
| 2026-01-23 | $1.34 | 131,200 |
| 2026-01-22 | $1.40 | 128,500 |
| 2026-01-21 | $1.54 | 226,800 |
| 2026-01-20 | $1.60 | 142,100 |
| 2026-01-16 | $1.85 | 37,600 |
| 2026-01-15 | $1.89 | 87,500 |
| 2026-01-14 | $1.75 | 43,600 |
| 2026-01-13 | $1.72 | 45,800 |
| 2026-01-12 | $1.84 | 195,600 |
| 2026-01-09 | $1.68 | 39,600 |
| 2026-01-08 | $1.70 | 28,200 |
| 2026-01-07 | $1.68 | 124,000 |
| 2026-01-06 | $1.85 | 322,300 |
| 2026-01-05 | $1.69 | 162,900 |
About Allurion Technologies Inc.
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as provides access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company operates in Spain, France, Turkey, and internationally. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.
đ° Latest News
Zacks Industry Outlook Highlights Boston Scientific, Insulet, BioLife Solutions and Allurion
Zacks âĸ 2025-11-18T09:01:00Z
4 Medical Product Stocks to Watch From a Challenging Industry
Zacks âĸ 2025-11-17T14:20:00Z
Allurion Technologies Inc (ALUR) Q3 2025 Earnings Call Highlights: Strategic Restructuring and ...
GuruFocus.com âĸ 2025-11-12T21:04:06ZAllurion Technologies, Inc. (ALUR) Reports Q2 Loss, Misses Revenue Estimates
Zacks âĸ 2025-08-19T22:40:02Z
Allurion Technologies Inc (ALUR) Q2 2025 Earnings Call Highlights: Strategic Pivot and Cost ...
GuruFocus.com âĸ 2025-08-14T07:08:33ZBioLife Solutions, Inc. (BLFS) Reports Break-Even Earnings for Q2
Zacks âĸ 2025-08-07T21:20:01Z
Flora Growth Corp. (FLGC) Reports Q2 Loss, Tops Revenue Estimates
Zacks âĸ 2025-08-01T21:15:01Z
Zynex Inc. (ZYXI) Reports Q2 Loss, Misses Revenue Estimates
Zacks âĸ 2025-07-31T21:35:05Z
Allurion Technologies Inc. (ALUR) Returns to France with 12.2% Weight Loss, 6.6% Muscle Gain Results
Insider Monkey âĸ 2025-05-27T23:51:25Z
Allurion Technologies Inc (ALUR) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ...
GuruFocus.com âĸ 2025-05-15T07:12:00ZIncome Statement (Annual)
Revenue
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Reconciled Cost Of Revenue | $10,607,000 | $11,970,000 | $13,485,000 | $9,052,000 |
| Cost Of Revenue | $10,607,000 | $11,970,000 | $13,485,000 | $9,052,000 |
| Total Revenue | $32,110,000 | $53,467,000 | $64,211,000 | $38,242,000 |
| Operating Revenue | $32,110,000 | $53,467,000 | $64,211,000 | $38,242,000 |
Expenses
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Interest Expense | $2,264,000 | $10,566,000 | $4,426,000 | $3,668,000 |
| Total Expenses | $82,308,000 | $132,545,000 | $96,221,000 | $50,743,000 |
| Other Income Expense | $45,982,000 | $7,091,000 | $-1,165,000 | $3,783,000 |
| Other Non Operating Income Expenses | $19,542,000 | $-4,394,000 | $-344,000 | $-555,000 |
| Net Non Operating Interest Income Expense | $-2,264,000 | $-10,566,000 | $-4,426,000 | $-3,668,000 |
| Interest Expense Non Operating | $2,264,000 | $10,566,000 | $4,426,000 | $3,668,000 |
| Operating Expense | $71,701,000 | $120,575,000 | $82,736,000 | $41,691,000 |
| Selling And Marketing Expense | $25,933,000 | $46,857,000 | $50,405,000 | $27,144,000 |
| General And Administrative Expense | $28,399,000 | $46,024,000 | $15,365,000 | $8,818,000 |
Income & Earnings
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $-7,198,000 | $-82,817,000 | $-37,744,000 | $-12,386,000 |
| Net Interest Income | $-2,264,000 | $-10,566,000 | $-4,426,000 | $-3,668,000 |
| Normalized Income | $-28,085,600 | $-91,890,150 | $-37,095,410 | $-16,724,000 |
| Net Income From Continuing And Discontinued Operation | $-7,198,000 | $-82,817,000 | $-37,744,000 | $-12,386,000 |
| Total Operating Income As Reported | $-50,198,000 | $-79,078,000 | $-32,010,000 | $-12,501,000 |
| Net Income Common Stockholders | $-7,198,000 | $-84,514,000 | $-40,651,000 | $-13,626,000 |
| Net Income | $-7,198,000 | $-82,817,000 | $-37,744,000 | $-12,386,000 |
| Net Income Including Noncontrolling Interests | $-7,198,000 | $-82,817,000 | $-37,744,000 | $-12,386,000 |
| Net Income Continuous Operations | $-7,198,000 | $-82,817,000 | $-37,744,000 | $-12,386,000 |
| Pretax Income | $-6,480,000 | $-82,553,000 | $-37,601,000 | $-12,386,000 |
| Special Income Charges | $14,187,000 | $7,523,000 | $0 | $4,375,000 |
| Operating Income | $-50,198,000 | $-79,078,000 | $-32,010,000 | $-12,501,000 |
| Gross Profit | $21,503,000 | $41,497,000 | $50,726,000 | $29,190,000 |
Per Share Metrics
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Diluted EPS | $-11.64 | $-57.75 | $-21.85 | $-7.33 |
| Basic EPS | $-11.64 | $-57.75 | $-21.85 | $-7.33 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | $5,552,400 | $2,411,850 | $-172,410 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-29,910,000 | $-82,726,000 | $-31,459,000 | $-12,349,000 |
| Total Unusual Items | $26,440,000 | $11,485,000 | $-821,000 | $4,338,000 |
| Total Unusual Items Excluding Goodwill | $26,440,000 | $11,485,000 | $-821,000 | $4,338,000 |
| Reconciled Depreciation | $746,000 | $746,000 | $895,000 | $707,000 |
| EBITDA (Bullshit earnings) | $-3,470,000 | $-71,241,000 | $-32,280,000 | $-8,011,000 |
| EBIT | $-4,216,000 | $-71,987,000 | $-33,175,000 | $-8,718,000 |
| Diluted Average Shares | $2,247,164 | $1,423,266 | $1,860,080 | $1,860,080 |
| Basic Average Shares | $2,247,164 | $1,423,266 | $1,860,080 | $1,860,080 |
| Diluted NI Availto Com Stockholders | $-7,198,000 | $-84,514,000 | $-40,651,000 | $-13,626,000 |
| Tax Provision | $718,000 | $264,000 | $143,000 | $0 |
| Other Special Charges | $8,713,000 | $21,527,000 | - | $-4,375,000 |
| Restructuring And Mergern Acquisition | $-22,900,000 | $-29,050,000 | $0 | - |
| Gain On Sale Of Security | $12,253,000 | $3,962,000 | $-821,000 | $-37,000 |
| Research And Development | $17,369,000 | $27,694,000 | $16,966,000 | $5,729,000 |
| Selling General And Administration | $54,332,000 | $92,881,000 | $65,770,000 | $35,962,000 |
| Other Gand A | $28,399,000 | $46,024,000 | $15,365,000 | $8,818,000 |
| Preferred Stock Dividends | - | $1,697,000 | $2,907,000 | $1,240,000 |
Balance Sheet (Annual)
Assets
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Tangible Assets | $-77,978,000 | $-71,297,000 | $-32,314,000 | $-34,285,000 |
| Total Assets | $32,813,000 | $71,712,000 | $51,370,000 | $39,351,000 |
| Total Non Current Assets | $5,657,000 | $6,896,000 | $7,987,000 | $2,025,000 |
| Other Non Current Assets | $1,109,000 | $505,000 | $2,706,000 | $311,000 |
| Current Assets | $27,156,000 | $64,816,000 | $43,383,000 | $37,326,000 |
| Other Current Assets | $1,243,000 | $2,414,000 | $2,487,000 | $1,936,000 |
| Inventory | $3,400,000 | $6,171,000 | $3,865,000 | $2,715,000 |
| Receivables | $7,134,000 | $18,194,000 | $29,346,000 | $6,832,000 |
| Accounts Receivable | $7,134,000 | $18,194,000 | $29,346,000 | $6,832,000 |
| Allowance For Doubtful Accounts Receivable | $-6,701,000 | $-12,671,000 | $-741,000 | $-354,000 |
| Gross Accounts Receivable | $13,835,000 | $30,865,000 | $30,087,000 | $7,186,000 |
| Cash Cash Equivalents And Short Term Investments | $15,379,000 | $38,037,000 | $7,685,000 | $25,843,000 |
| Cash And Cash Equivalents | $15,379,000 | $38,037,000 | $7,685,000 | $25,843,000 |
Debt
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Debt | $20,331,000 | $606,000 | $48,778,000 | $300,000 |
| Total Debt | $37,923,000 | $41,857,000 | $59,531,000 | $26,143,000 |
| Long Term Debt And Capital Lease Obligation | $37,054,000 | $2,306,000 | $5,266,000 | $2,003,000 |
| Long Term Debt | $35,710,000 | - | $3,103,000 | $2,003,000 |
| Current Debt And Capital Lease Obligation | $869,000 | $39,551,000 | $54,265,000 | $24,140,000 |
| Current Debt | - | $38,643,000 | $53,360,000 | $24,140,000 |
| Other Current Borrowings | - | $38,643,000 | $53,360,000 | $24,140,000 |
Liabilities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Liabilities Net Minority Interest | $110,791,000 | $143,009,000 | $83,684,000 | $73,636,000 |
| Total Non Current Liabilities Net Minority Interest | $91,928,000 | $77,584,000 | $7,817,000 | $42,025,000 |
| Other Non Current Liabilities | $50,307,000 | $68,513,000 | $2,551,000 | $900,000 |
| Derivative Product Liabilities | $4,567,000 | $6,765,000 | $0 | - |
| Current Liabilities | $18,863,000 | $65,425,000 | $75,867,000 | $31,611,000 |
| Payables And Accrued Expenses | $16,948,000 | $24,187,000 | $18,149,000 | $5,042,000 |
| Payables | $6,572,000 | $10,379,000 | $5,809,000 | $1,618,000 |
| Accounts Payable | $6,572,000 | $10,379,000 | $5,809,000 | $1,618,000 |
| Interest Payable | - | $0 | $489,000 | $0 |
| Current Deferred Liabilities | - | - | $0 | $202,000 |
Equity
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Common Stock Equity | $-77,978,000 | $-71,297,000 | $-32,314,000 | $-92,258,000 |
| Total Equity Gross Minority Interest | $-77,978,000 | $-71,297,000 | $-32,314,000 | $-34,285,000 |
| Stockholders Equity | $-77,978,000 | $-71,297,000 | $-32,314,000 | $-34,285,000 |
| Gains Losses Not Affecting Retained Earnings | $-8,370,000 | $700,000 | $0 | - |
| Other Equity Adjustments | $-8,370,000 | $700,000 | - | - |
| Retained Earnings | $-222,207,000 | $-215,009,000 | $-132,192,000 | $-94,448,000 |
| Preferred Stock Equity | - | - | $57,999,000 | $57,973,000 |
| Preferred Securities Outside Stock Equity | - | - | $39,122,000 | $39,122,000 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Ordinary Shares Number | $2,710,607 | $1,907,523 | $1,860,080 | $1,860,080 |
| Share Issued | $2,710,607 | $1,907,523 | $1,860,080 | $1,860,080 |
| Tangible Book Value | $-77,978,000 | $-71,297,000 | $-32,314,000 | $-92,258,000 |
| Invested Capital | $-42,268,000 | $-32,654,000 | $24,149,000 | $-66,115,000 |
| Working Capital | $8,293,000 | $-609,000 | $-32,484,000 | $5,715,000 |
| Capital Lease Obligations | $2,213,000 | $3,214,000 | $3,068,000 | $0 |
| Total Capitalization | $-42,268,000 | $-71,297,000 | $-29,211,000 | $-32,282,000 |
| Additional Paid In Capital | $152,596,000 | $143,010,000 | $99,877,000 | $2,139,000 |
| Capital Stock | $3,000 | $2,000 | $1,000 | $58,024,000 |
| Common Stock | $3,000 | $2,000 | $1,000 | $51,000 |
| Preferred Stock | $0 | $0 | $0 | $57,973,000 |
| Long Term Capital Lease Obligation | $1,344,000 | $2,306,000 | $2,163,000 | $0 |
| Current Capital Lease Obligation | $869,000 | $908,000 | $905,000 | $0 |
| Pensionand Other Post Retirement Benefit Plans Current | $1,046,000 | $1,687,000 | $3,453,000 | $2,227,000 |
| Current Accrued Expenses | $10,376,000 | $13,808,000 | $12,340,000 | $3,424,000 |
| Net PPE | $4,548,000 | $6,391,000 | $5,281,000 | $1,714,000 |
| Accumulated Depreciation | $-4,357,000 | $-3,559,000 | $-2,851,000 | $-1,987,000 |
| Gross PPE | $8,905,000 | $9,950,000 | $8,132,000 | $3,701,000 |
| Leases | $1,943,000 | $1,943,000 | $1,822,000 | $1,755,000 |
| Construction In Progress | $14,000 | $1,195,000 | $583,000 | $13,000 |
| Other Properties | $2,079,000 | $3,010,000 | $2,899,000 | - |
| Machinery Furniture Equipment | $4,869,000 | $3,802,000 | $2,828,000 | $1,933,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $1,789,000 | $3,427,000 | $2,096,000 | $1,609,000 |
| Work In Process | $763,000 | $967,000 | $213,000 | $216,000 |
| Raw Materials | $848,000 | $1,777,000 | $1,556,000 | $890,000 |
| Current Deferred Revenue | - | - | $0 | $202,000 |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | $-65,588,000 | $-65,588,000 | $-48,531,000 | $-15,241,000 |
Operating Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Operating Cash Flow | $-63,982,000 | $-63,982,000 | $-46,981,000 | $-14,329,000 |
| Cash Flow From Continuing Operating Activities | $-63,982,000 | $-63,982,000 | $-46,981,000 | $-14,329,000 |
| Operating Gains Losses | $-693,000 | $-2,885,000 | $726,000 | $-1,367,000 |
Investing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Capital Expenditure | $-1,606,000 | $-1,606,000 | $-1,550,000 | $-912,000 |
| Investing Cash Flow | $-1,606,000 | $-1,606,000 | $-1,550,000 | $-912,000 |
| Cash Flow From Continuing Investing Activities | $-1,606,000 | $-1,606,000 | $-1,550,000 | $-912,000 |
Financing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Issuance Of Capital Stock | $0 | $0 | $0 | $9,871,000 |
| Financing Cash Flow | $95,986,000 | $95,986,000 | $30,537,000 | $28,945,000 |
| Cash Flow From Continuing Financing Activities | $95,986,000 | $95,986,000 | $30,537,000 | $28,945,000 |
| Net Other Financing Charges | $95,702,000 | $95,702,000 | $-548,000 | $-522,000 |
| Net Common Stock Issuance | $0 | $0 | - | - |
| Common Stock Issuance | $0 | $0 | - | - |
| Net Preferred Stock Issuance | - | - | $0 | $9,871,000 |
| Preferred Stock Issuance | - | - | $0 | $9,871,000 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Repayment Of Debt | $-88,409,000 | $-88,409,000 | $0 | $-29,396,000 |
| Issuance Of Debt | $88,480,000 | $88,480,000 | $30,953,000 | $48,469,000 |
| Interest Paid Supplemental Data | $8,035,000 | $8,035,000 | $3,476,000 | $1,321,000 |
| End Cash Position | $38,421,000 | $38,421,000 | $8,023,000 | $26,017,000 |
| Beginning Cash Position | $8,023,000 | $8,023,000 | $26,017,000 | $12,313,000 |
| Changes In Cash | $30,398,000 | $30,398,000 | $-17,994,000 | $13,704,000 |
| Proceeds From Stock Option Exercised | $213,000 | $213,000 | $132,000 | $523,000 |
| Net Issuance Payments Of Debt | $71,000 | $71,000 | $30,953,000 | $19,073,000 |
| Net Long Term Debt Issuance | $71,000 | $71,000 | $30,953,000 | $19,073,000 |
| Long Term Debt Payments | $-88,409,000 | $-88,409,000 | $0 | $-29,396,000 |
| Long Term Debt Issuance | $88,480,000 | $88,480,000 | $30,953,000 | $48,469,000 |
| Net PPE Purchase And Sale | $-1,606,000 | $-1,606,000 | $-1,550,000 | $-912,000 |
| Purchase Of PPE | $-1,606,000 | $-1,606,000 | $-1,550,000 | $-912,000 |
| Interest Paid Cfo | $-1,092,000 | $-1,092,000 | $0 | - |
| Change In Working Capital | $194,000 | $194,000 | $-13,788,000 | $-1,495,000 |
| Change In Other Current Liabilities | $-789,000 | $-789,000 | $-733,000 | $0 |
| Change In Payables And Accrued Expense | $5,721,000 | $5,721,000 | $11,489,000 | $2,086,000 |
| Change In Accrued Expense | $1,057,000 | $1,057,000 | $8,165,000 | $2,574,000 |
| Change In Payable | $4,664,000 | $4,664,000 | $3,324,000 | $-488,000 |
| Change In Account Payable | $4,664,000 | $4,664,000 | $3,324,000 | $-488,000 |
| Change In Prepaid Assets | $285,000 | $285,000 | $-577,000 | $-1,369,000 |
| Change In Inventory | $-3,705,000 | $-3,705,000 | $-1,150,000 | $-1,285,000 |
| Change In Receivables | $-1,318,000 | $-1,318,000 | $-22,817,000 | $-927,000 |
| Changes In Account Receivables | $-1,318,000 | $-1,318,000 | $-22,817,000 | $-927,000 |
| Other Non Cash Items | $-4,961,000 | $-4,961,000 | $2,057,000 | $-321,000 |
| Stock Based Compensation | $8,357,000 | $8,357,000 | $437,000 | $313,000 |
| Provisionand Write Offof Assets | $14,074,000 | $14,074,000 | $436,000 | $220,000 |
| Depreciation Amortization Depletion | $746,000 | $746,000 | $895,000 | $707,000 |
| Depreciation And Amortization | $746,000 | $746,000 | $895,000 | $707,000 |
| Depreciation | $746,000 | $746,000 | $895,000 | $707,000 |
| Gain Loss On Investment Securities | $-4,442,000 | $-6,634,000 | $839,000 | $240,000 |
| Net Foreign Currency Exchange Gain Loss | $-180,000 | $-180,000 | $-113,000 | - |
| Net Income From Continuing Operations | $-80,607,000 | $-82,817,000 | $-37,744,000 | $-12,386,000 |
| Unrealized Gain Loss On Investment Securities | - | $4,402,000 | $0 | - |